Pacific Biosciences of California Inc

NASDAQ:PACB 3:59:54 PM EDT

29.37

+0.59 (+2.05%)

4:46:03 PM EDT: $29.59 +0.22 (+0.75%)

Market Cap (Intraday)	5.77B
Current PE	196.17
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$25.58 Million
Adjusted EPS	-$0.41

See more estimates

10-Day MA	$32.55
50-Day MA	$34.92
200-Day MA	$15.71

See more pivots

Pacific Biosciences of California, Inc. Stock, NASDAQ:PACB

1305 O'Brien Drive, Menlo Park, California 94025

United States of America

Phone: +1.650.521.8000

Number of Employees: 404

http://www.pacb.com

Description

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.